Evidence map›Paper›PMID 22226633›Full record

ArticleImmunity2012

TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils.

Adebusola Alagbala Ajibade, Qinfu Wang, Jun Cui, Jia Zou, Xiaojun Xia, Mingjun Wang, Yanzheng Tong, Wei Hui, Dou Liu, Bing Su and 2 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 100 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 1 synthesis or guideline pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. TScience advances · 2025
    Article
  3. RGMb drives macrophage infiltration to aggravate kidney disease.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Intercalated cell function, kidney innate immunity, and urinary tract infections.Pflugers Archiv : European journal of physiology · 2024
    Review
  6. Review
  7. Dying to Defend: Neutrophil Death Pathways and their Implications in Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  8. Global trends in PANoptosis research: bibliometrics and knowledge graph analysis.Apoptosis : an international journal on programmed cell death · 2024
    Article
  9. Article
  10. Immune defenses in the urinary tract.Trends in immunology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pyroptosis-Induced Inflammation and Tissue Damage.Journal of molecular biology · 2022
    Review
  19. Article
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Adebusola Alagbala AjibadeCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Qinfu Wang
Jun Cui
Jia Zou
Xiaojun Xia
Mingjun Wang
Yanzheng Tong
Wei Hui
Dou Liu
Bing Su
Helen Y Wang
Rong-Fu Wang
Baylor College of Medicine · USHouston Methodist · USYale University · US

Funding

VECTOR PRODUCTIONP01CA094237 · NCI · BAYLOR COLLEGE OF MEDICINE · PI HESLOP, HELEN E, ROONEY, CLIONA M. · 2002 to 2017
$27.8M
Novel Strategies for Intervention of Inflammatory Diseases and Cancer - Research Supplement to R01-CA101795R01CA101795 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, RONGFU · 2004 to 2022
$4.6M
The Role of CD4+ T Cells in Antitumor ImmunityR01CA090327 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI WANG, RONGFU · 2002 to 2013
$3.0M
Regulation and Function of MEKK3 in Dendritic CellsR01AI063348 · NIAID · YALE UNIVERSITY · PI SU, BING · 2005 to 2009
$1.8M
Development of Novel Vaccines for Cocaine AbuseR01DA030338 · NIDA · METHODIST HOSPITAL RESEARCH INSTITUTE · PI ORSON, FRANK M, WANG, RONGFU · 2010 to 2014
$1.6M
Molecular Mechanisms of MEKK3-Signaling in AngiogenesisR01HL070225 · NHLBI · YALE UNIVERSITY · PI SU, BING · 2003 to 2006
$1.3M
Antigen specificity, suppressive mechanism & regulation of CD4+ regulatory T cellR01CA116408 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI WANG, RONGFU · 2006 to 2010
$1.3M
Reversal of regulatory T cell function in prostate cancerR01CA121191 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI WANG, RONGFU · 2006 to 2010
$1.3M
NCI NIH HHS P01 CA094237NCI NIH HHS R01 CA090327NCI NIH HHS R01 CA101795NCI NIH HHS R01 CA116408NCI NIH HHS R01 CA121191NHLBI NIH HHS R01 HL070225NIAID NIH HHS R01 AI063348NIDA NIH HHS R01 DA030338
6 · The paper itself

Abstract

Stringent control of NF-κB and mitogen-activated protein kinase (MAPK) signaling is critical during innate immune responses. TGF-β activated kinase-1 (TAK1) is essential for NF-κB activation in T and B cells but has precisely the opposite activity in myeloid cells. Specific deletion of TAK1 (Map3k7(ΔM/ΔM)) led to development of splenomegaly and lymphomegaly associated with neutrophilia. Compared with wild-type cells, TAK1-deficient neutrophils enhanced the phosphorylation of the kinases IKK, p38, and JNK and the production of interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), and reactive oxygen species (ROS) after lipopolysaccharide (LPS) stimulation. Map3k7(ΔM/ΔM) mice were significantly more susceptible to LPS-induced septic shock and produced higher amounts of IL-1β, IL-6, and TNF-α in plasma than do wild-type mice. Specific ablation of p38 rescued the phenotype and functional properties of Map3k7(ΔM/ΔM) mice. Our findings identify a previously unrecognized role of TAK1 as a negative regulator of p38 and IKK activation in a cell type-specific manner.

Indexed as

CD11b AntigenReceptors, ChemokineAnimalsApoptosisCell ProliferationDown-RegulationGene DeletionMacrophagesMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMiceMice, KnockoutModels, ImmunologicalNeutrophilsNF-kappa Bp38 Mitogen-Activated Protein KinasesCD11b AntigenGr-1 protein, mouseMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesNF-kappa Bp38 Mitogen-Activated Protein KinasesReceptors, Chemokine

Identifiers

PMID22226633
PMCPMC3750978
OpenAlexW2083337723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.